Lawyer: Without Post-Appeal Adjustment, TPE May Go Down Bad Path

When a provider’s claims for facet joint injections ran the gauntlet of Targeted Probe and Educate (TPE), 64% were denied by the Medicare administrative contractor (MAC). A high denial rate isn’t uncommon for pain management procedures, which are under the microscope, attorneys say. But the provider’s luck changed at the second level of appeal. After the provider called attention to entries in the documentation that supported the medical necessity of the facet joint injections, the qualified independent contractor (QIC) overturned most of the claim denials, and now 64% have been approved, a mirror image of the original findings, according to the attorney who represents the provider.

But it’s too soon for the provider to celebrate, said Richelle Marting, an attorney and certified coder in Olathe, Kansas. The MAC isn’t adjusting the TPE error rate to account for the overturned claim denials, leaving the provider vulnerable to prepayment review and extrapolated overpayment findings, she said. With the provider on the cusp of TPE round two, Marting notified the nurse reviewer at the MAC, WPS Medicare, every time she received a notice that a claim denial was overturned. But Marting said the nurse reviewer told her the MAC doesn’t adjust the provider’s error rate based on the outcome of the appeal. As far as the MAC is concerned, the error rate is 64%, Marting said.

This document is only available to subscribers. Please log in or purchase access.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field